Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-23-000321
Filing Date
2023-03-07
Accepted
2023-03-07 08:31:24
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e4462_10q.htm   iXBRL 10-Q 682337
2 EXHIBIT 31.1 e4462_ex31-1.htm EX-31.1 8366
3 EXHIBIT 31.2 e4462_ex31-2.htm EX-31.2 8257
4 EXHIBIT 32.1 e4462_ex32-1.htm EX-32.1 4724
5 EXHIBIT 32.2 e4462_ex32-2.htm EX-32.2 4684
  Complete submission text file 0001731122-23-000321.txt   4205924

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enob-20220930.xsd EX-101.SCH 35702
7 XBRL CALCULATION FILE enob-20220930_cal.xml EX-101.CAL 44068
8 XBRL DEFINITION FILE enob-20220930_def.xml EX-101.DEF 138317
9 XBRL LABEL FILE enob-20220930_lab.xml EX-101.LAB 299509
10 XBRL PRESENTATION FILE enob-20220930_pre.xml EX-101.PRE 246851
52 EXTRACTED XBRL INSTANCE DOCUMENT e4462_10q_htm.xml XML 542251
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38758 | Film No.: 23711107
SIC: 2834 Pharmaceutical Preparations